Adverse Change in Employment Post-MI Tied to Worse Outcomes

Share this content:
Adverse Change in Employment Post-MI Tied to Worse Outcomes
Adverse Change in Employment Post-MI Tied to Worse Outcomes

TUESDAY, June 12, 2018 (HealthDay News) -- Patients with an adverse change in employment after myocardial infarction (MI) have increased likelihood of worse outcomes, according to a study published online June 12 in Circulation: Cardiovascular Quality and Outcomes.

Haider J. Warraich, M.D., from the Duke University Medical Center in Durham, N.C., and colleagues examined employment status at baseline and one year among 9,319 patients with MI enrolled at 233 U.S. hospitals. An adverse change in employment was defined as patients working at baseline but working less or not working at one year post-MI.

The researchers found that 51 percent of patients were employed at the time of MI. Ten percent of these reported an adverse change in employment by one year post-MI, with 3 and 7 percent working less and no longer working, respectively. A number of unplanned readmissions, post-discharge bleeding complications, hypertension, and smoking were factors significantly associated with adverse change in employment. There was an increased likelihood of reporting depression, lower health status, and moderate-to-extreme financial hardship with medication costs at one year for patients with an adverse change in employment.

"Patients who experienced an adverse change in employment after MI reported lower quality of life, increased depression, and more difficulty affording medications," the authors write. "These results underscore the need for interventions to address this patient-centered outcome and its health impact."

Several authors disclosed financial ties to pharmaceutical companies, including Lilly, which provided funding for the study, as did Daiichi Sankyo.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »